Summary

Eligibility
for people ages 10-18 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Mohammad Diab, MD
Headshot of Mohammad Diab
Mohammad Diab

Description

Summary

This study aims to investigate the effects of conditioning with open-label placebos on standard postoperative treatment for patients undergoing surgery for idiopathic scoliosis in a randomized controlled, 6-week trial with 64 AIS patients randomly assigned to one of two arms: Open-label Placebo (COLP) + treatment as usual TAU / TAU control. The study involves collecting data from your child's medical record. At each regular clinic visit, the patient clinical data will be collected by the research coordinator. Surveys will be collected including:• PROMIS for the age group 10 to 18 years.

Official Title

Effectiveness of Conditioning + Open-label Placebo for the Management of Pain in Children Who Undergo Surgical Treatment of Idiopathic Scoliosis

Details

Keywords

Adolescent Idiopathic Scoliosis (AIS), Conditioning with Open-Label Placebo (COLP), Scoliosis

Eligibility

Location

  • UCSF accepting new patients
    San Francisco California 94158 United States

Lead Scientist at UCSF

  • Mohammad Diab, MD
    Dr. Mohammad Diab is a Professor in the Department of Orthopaedic Surgery and the Department of Pediatrics at UCSF. Dr. Diab sees children and adolescents with the full spectrum of musculoskeletal conditions, from fractures to infections to bone deformity to congenital anomalies to neuromuscular disorders to skeletal dysplasias.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
Links
Mohammad Diab, MD
ID
NCT06365892
Phase
Phase 2/3 research study
Study Type
Interventional
Participants
Expecting 64 study participants
Last Updated